An Open-label, Multicenter, Phase I/II Study of AT-101 in Combination With Topotecan in Patients With Relapsed or Refractory Small Cell Lung Cancer After Prior Platinum Containing First Line Chemotherapy
Каталог · ЕАЭС
Клинические исследования и проекты
Ascenta Therapeutics · найдено 3
3 исследования
Завершено
Фаза I–II
Россия
AT-101; topotecan · Ascenta Therapeutics
Завершено
Фаза II
Россия
AT-101 and docetaxel; placebo and docetaxel · Ascenta Therapeutics
A Phase 2, Randomized, 2-Arm, Double-Blind Study of AT-101 in Combination With Docetaxel Versus Docetaxel Plus Placebo in Patients With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)
Завершено
Фаза II
Россия
AT-101, prednisone and docetaxel; placebo, prednisone and docetaxel · Ascenta Therapeutics
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)